Next-Gen TIL: Counteracting the Solid Tumor Microenvironment
Time: 9:30 am
day: Conference Day One
Details:
- Targeting immune checkpoint targets using gene editing
- Developing tethered cytokine approaches to increase TIL persistence post-infusion
- Enhancing tumor-specific immunity through enrichment and selection
